1,557
Participants
Start Date
May 6, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
May 31, 2026
Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Reduced Dose IPV
Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Reduced Dose IPV for active immunization of infants as 3 dose regimen (6, 10 \& 14 weeks) for primary vaccination and booster dose at the age of 12-24 months.
Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Full Dose IPV
Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Full Dose IPV for active immunization of infants as 3 dose regimen (6, 10 \& 14 weeks) for primary vaccination and booster dose at the age of 12-24 months.
RECRUITING
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Dhaka
RECRUITING
Hamdard Institute of Medical Sciences and Research (HIMSR) with Centre for health research & Development, Society for applied studies, Hakeem Abdul Hameed Centenary Hospital (HAHCH), New Delhi
RECRUITING
Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh
RECRUITING
Bharati Vidyapeeth Medical College and Hospital, Pune, Pune
RECRUITING
KEM Hospital and Research Centre, Vadu, Pune
RECRUITING
JSS Medical College and Hospital, Mysore
RECRUITING
Manipal Academy of Higher Education, Manipal, Mangalore
RECRUITING
Sri Ramachandra Medical Centre, Chennai, Chennai
RECRUITING
Institute of Child Health, Kolkata, Kolkata
Serum Institute of India Pvt. Ltd.
INDUSTRY